Global Becker Muscular Dystrophy Treatment Market By Treatment (Drugs, Corticosteroids, Angiotensin-Converting Enzyme (ACE) Inhibitors, Physical Therapy, Exercise, Braces, Mobility Aids, Breathing Assistance, Molecular Therapy, Gene Replacement Therapy, Stem Cell Research, Protein Production Alteration, Myoblast Transplantation), Diagnosis (Enzyme Assay, Genetic Testing, Electromyography, Biopsy), End User (Hospitals, Home Care Settings, Clinics, Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028